The global autogenous vaccines market is expected to grow at a CAGR

The global autogenous vaccines market is expected to grow at a CAGR of about 4.3 % in the forecast period of 2022-2027. As per the analysis by Expert Market Research, the market is expected to be driven by the increasing prevalence of contagious diseases.

The market is being driven positively by the rising provision of funds by governments and international communities to curb and eliminate animal diseases and focus on the immunisation of animals. Furthermore, steps taken by European Animal Health Strategy Programs, Center for Disease Prevention and Control, Food and Agriculture Organization, and World Organization for Animal Health (OIE) have contributed to the industry’s growth. The outbreak of contagious diseases in livestock and the susceptibility of animals for pink eye and peste des petits ruminants (PPR) further increases the demand for customised autogenous vaccines.

In August 2022, Elanco Animal Health Inc (NYSE: ELAN) announced a collaboration with AgNext at Colorado State University in the United States. The strategic partnership is focused on transforming sustainability for producers of livestock with new solutions targeted towards sustainability for animal agriculture. In March 2022, Apiam Animal Health announced the setup of the first dedicated facility in Australia for autogenous viral vaccines. To be managed with support of La Trobe University, vaccines under development include Japanese Encephalitis Virus or JEV. The entire facility is expected to be complete by 2025.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Top 5 Companies in the World:

Newport Laboratories, Inc.

Newport Laboratories Inc is an American biotechnology company that provides laboratory products and services, offering preventative and diagnostic technologies to prevent animal diseases for practising veterinarians and producers. The company has the largest private diagnostic lab in the United States. It provides custom made vaccines for swine and bovine to address livestock diseases like pinkeye, Salmonellosis, Erysipelas, Clostridium difficile, and others. Newport Laboratories has about 120 employees in laboratories and offices.

Elanco Animal Health Inc.

Elanco Animal Health Inc. is a US-based animal healthcare company. The company develops, manufactures, and markets medicines, vaccinations, productivity enhancers, diagnostic tools and services, antibacterial and parasite control treatments for livestock and pets. It provides products through more than 200 brands for cats, dogs, swine, cows, poultry animals and other farm animals in over 90 countries worldwide. Elanco Animal Health Inc recorded an annual revenue of ESD 4,765 million in 2021.

Cambridge Technologies

Cambridge Technologies is an American biotechnology company that researches, develops, and markets products to identify emerging pathogens, prevent diseases and reduce dependence on antibiotics. The company provides autogenous vaccines using the Precision Vaccinology technology, metagenomics, genetic sequencing, qPCR, culture, sensitivity, and serology for processing the vaccines to prevent diseases in bovine, swine, and other farms animals. It supplies the custom vaccines to veterinarians and livestock producers through its USDA-licensed 37,000-square-foot manufacturing facility.

Hygieia Biological Laboratories

Hygieia Biological Laboratories is a US-based research and development laboratory engaged in manufacturing veterinary products, human biologics, and pharmaceuticals globally. The company provides its vaccines for beef and dairy cattle, sheep, poultry, and other livestock animals. It is the only company in the world to provide a vaccine against venom, Foot Warts, and Streptococcus uberis mastitis. The autogenous vaccines it supplies are for Corynebacterium pseudotuberculosis bacterin-toxoids, Salmonella bacterins, and other diseases.

AniCon Labor GmbH

AniCon Labor GmbH is a leading producer of autogenous vaccines in Europe. The German company provides veterinary diagnostics and livestock-specific vaccines for farm animals and food safety. It has a state-of-the-art lab centre that produces more than 50 bacterial and 15 viral antigen vaccines for various species of poultry, swine, cattle, sheep, goats, and fish. The company also produces In-Vitro-Diagnostics (IVD) such as PCR kits under its brand Kylt®.